Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|17|2883-2891

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.17, 2015-09, pp. : 2883-2891

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig   Lamanna Nicole   Weiss Mark A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

By  

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-10 ,pp. : 689-700

Bentham Science Publishers

Access to resources Recommend Favorite

Bendamustine for treatment of chronic lymphocytic leukemia

By Chang Julie Elizabeth   Kahl Brad Steven  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Lenalidomide in lymphomas and chronic lymphocytic leukemia

By Wiernik Peter H  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 475-488

Informa Healthcare

Access to resources Recommend Favorite

The current role of high-dose imatinib in chronic myeloid leukemia patients, newly diagnosed or resistant to standard dose

By Breccia Massimo   Alimena Giuliana  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2075-2087

Informa Healthcare

Access to resources Recommend Favorite